Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.02 is 36% above its 5-year average of 0.01, near the low end of its 5-year range (0.01–0.05).
As of the fiscal period ended Tuesday, June 30, 2026. 17.49% above its 12-month average of 0.02.
Reported quarterly debt to equity ratio; no daily interpolation.
DEBT TO EQUITY RATIO
0.02
DEBT TO EQUITY RATIO AVG TTM
0.02
DEBT TO EQUITY RATIO AVG 3Y
0.01
DEBT TO EQUITY RATIO AVG 5Y
0.01
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+17.49%
CURRENT VS 3Y AVG
+33.32%
CURRENT VS 5Y AVG
+36.16%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.69
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-97.40%
vs the sector median at left
Market Cap
$23.85B
Debt to Equity Ratio
0.10
TTM Avg
0.12
3Y Avg
0.12
5Y Avg
0.13
Market Cap
$25.66B
Debt to Equity Ratio
0.01
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
0.01
Market Cap
$25.87B
Debt to Equity Ratio
0.85
TTM Avg
1.00
3Y Avg
0.92
5Y Avg
0.85
Market Cap
$26.22B
Debt to Equity Ratio
164.70
TTM Avg
48.23
3Y Avg
26.06
5Y Avg
17.96
Market Cap
$26.39B
Debt to Equity Ratio
0.79
TTM Avg
0.87
3Y Avg
0.78
5Y Avg
0.74
Market Cap
$21.45B
Debt to Equity Ratio
0.00
TTM Avg
0.03
3Y Avg
0.09
5Y Avg
0.13
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $24.67B | 0.02 | 0.02 | 0.01 | 0.01 |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.85B | 0.10 | 0.12 | 0.12 | 0.13 |
| Incyte Corporation (INCY)vs › | $25.66B | 0.01 | 0.01 | 0.01 | 0.01 |
| Quest Diagnostics Incorporated (DGX)vs › | $25.87B | 0.85 | 1.00 | 0.92 | 0.85 |
| Mettler-Toledo International Inc. (MTD)vs › | $26.22B | 164.70 | 48.23 | 26.06 | 17.96 |
| Labcorp Holdings Inc. (LH)vs › | $26.39B | 0.79 | 0.87 | 0.78 | 0.74 |
| United Therapeutics Corporation (UTHR)vs › | $21.45B | 0.00 | 0.03 | 0.09 | 0.13 |
| STERIS plc (STE)vs › | $21.05B | 0.28 | 0.31 | 0.42 | 0.44 |
| Medline Inc. (MDLN)vs › | $28.94B | 1.09 | 1.09 | 1.06 | 1.06 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.51B | 0.92 | 1.04 | 1.09 | 0.74 |
Debt/Equity
0.02
Current Ratio
7.85
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.02 |
| 2026-03-31 | 0.02 |
| 2025-12-31 | 0.01 |
| 2025-09-30 | 0.01 |
| 2025-06-30 | 0.01 |
| 2025-03-31 | 0.02 |
| 2024-12-31 | 0.01 |
| 2024-09-30 | 0.01 |
| 2024-06-30 | 0.01 |
| 2024-03-31 | 0.01 |
| 2023-12-31 | 0.01 |
| 2023-09-30 | 0.01 |
| 2023-06-30 | 0.01 |
| 2023-03-31 | 0.01 |
| 2022-12-31 | 0.01 |
| 2022-09-30 | 0.01 |
| 2022-06-30 | 0.01 |
| 2022-03-31 | 0.01 |
| 2021-12-31 | 0.03 |
| 2021-09-30 | 0.03 |
| 2021-06-30 | 0.05 |
| 2021-03-31 | 0.10 |
| 2020-12-31 | 0.18 |
| 2020-09-30 | 0.18 |
| 2020-06-30 | 0.13 |
| 2020-03-31 | 0.16 |
| 2019-12-31 | 0.15 |
| 2019-09-30 | 0.16 |
| 2019-06-30 | 0.16 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 0.20 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
